Kirsty Lee Garson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kirsty Lee Garson has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Andrew Tarupiwa
National Microbiology Reference Laboratory, Harare, Zimbabwe
1 shared publicationB. Symington
Cardio‐Metabolic Research Group (CMRG) Department of Physiological Sciences Stellenbosch University Stellenbosch South Africa
1 shared publicationC. Kimar
Cardio‐Metabolic Research Group (CMRG) Department of Physiological Sciences Stellenbosch University Stellenbosch South Africa
1 shared publication- Danzil E. Joseph
Stellenbosch University
1 shared publication - Enock Havyarimana
Centre for Environmental Health and Sustainability, Division of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, United Kingdom; NIHR Leicester Biomedical Research Centre, Leicester General Hospital, Leicester, United Kingdom
1 shared publication Fortunate Mugabe
Harare Central Hospital, Zimbabwe, Harare, Zimbabwe
1 shared publication
Latest Publications
- Open Access
- 13 November 2019
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 221 (7) , 1194-1203
Human Immunodeficiency Virus Infection Is Associated With Preterm Delivery Independent of Vaginal Microbiota in Pregnant African Women
During pregnancy, the vaginal microbiota is relatively stable. However, African women have more diverse vaginal microbiota than their European counterparts, in addition to high human immunodeficiency virus (HIV) prevalence and risk of adverse birth outcomes. Although HIV is associated with alterations in vaginal microbiota and inflammation in nonpregnant women, these relationships are underexplored in pregnant women. In this study, we characterize the vaginal microbiota and immune factors in pregnant African women who were HIV-uninfected (n = 314) versus HIV-infected (n = 42). Mucosal samples were collected once at the enrollment visit (between 15 and 35 weeks of gestation) and women were followed until delivery. Vaginal microbial communities of pregnant women with HIV were significantly more diverse than women without HIV (P = .004), with community structure also differing by HIV status (P = .002, R2 = 0.02). Human immunodeficiency virus infection was also associated with increased risk of preterm birth (PTB) (31% versus 15.3%; P = .066). In a multivariate analysis, HIV infection was independently associated with diverse vaginal community state type (CST)-IVA (P = .005) and CST-IVB (P = .018) as well as PTB (P = .049). No association between HIV status and cytokine concentrations was found. Longitudinal studies with accurate gestational age assessment would be important to confirm these relationships.
- 13 November 2019
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 221 (7) , 1194-1203
Open AccessHuman Immunodeficiency Virus Infection Is Associated With Preterm Delivery Independent of Vaginal Microbiota in Pregnant African Women
During pregnancy, the vaginal microbiota is relatively stable. However, African women have more diverse vaginal microbiota than their European counterparts, in addition to high human immunodeficiency virus (HIV) prevalence and risk of adverse birth outcomes. Although HIV is associated with alterations in vaginal microbiota and inflammation in nonpregnant women, these relationships are underexplored in pregnant women. In this study, we characterize the vaginal microbiota and immune factors in pregnant African women who were HIV-uninfected (n = 314) versus HIV-infected (n = 42). Mucosal samples were collected once at the enrollment visit (between 15 and 35 weeks of gestation) and women were followed until delivery. Vaginal microbial communities of pregnant women with HIV were significantly more diverse than women without HIV (P = .004), with community structure also differing by HIV status (P = .002, R2 = 0.02). Human immunodeficiency virus infection was also associated with increased risk of preterm birth (PTB) (31% versus 15.3%; P = .066). In a multivariate analysis, HIV infection was independently associated with diverse vaginal community state type (CST)-IVA (P = .005) and CST-IVB (P = .018) as well as PTB (P = .049). No association between HIV status and cytokine concentrations was found. Longitudinal studies with accurate gestational age assessment would be important to confirm these relationships.
- 25 October 2013
- Published by Wiley in Acta Physiologica
- Vol. 210 (3) , 546-564
Detrimental effects of acute hyperglycaemia on the rat heart
Aim: Hyperglycaemia is an important risk factor for acute myocardial infarction. It can lead to increased induction of non‐oxidative glucose pathways (NOGPs) – polyol and hexosamine biosynthetic pathways, advanced glycation end products and protein kinase C – that may contribute to cardiovascular diseases onset. However, the precise underlying mechanisms remain poorly understood. Here we hypothesized that acute hyperglycaemia increases myocardial oxidative stress and NOGP activation resulting in cardiac dysfunction during ischaemia–reperfusion and that inhibition of, and/or shunting flux away from NOGPs [by benfotiamine (BFT) treatment], leads to cardioprotection.Methods: We employed several experimental systems: (i) Isolated rat hearts were perfused ex vivo with Krebs‐Henseleit buffer containing 33 mm glucose vs. controls (11 mm glucose) ± global ischaemia and reperfusion ± BFT (first 20 min of reperfusion); (ii) Infarct size determination as per the ischaemic protocol, but with regional ischaemia and reperfusion ± BFT treatment; in separate experiments, NOGP inhibitors were also employed for (i) and (ii); and (iii) In vivo coronary ligations performed on streptozotocin‐treated rats ± BFT treatment (early reperfusion).Results: Acute hyperglycaemia generated myocardial oxidative stress, NOGP activation and apoptosis, but caused no impairment of cardiac function during pre‐ischaemia, thereby priming hearts for later damage. Following ischaemia–reperfusion (under hyperglycaemic conditions), such effects were exacerbated together with cardiac contractile dysfunction. Moreover, inhibition of respective NOGPs and shunting away by BFT treatment (in part) improved cardiac function during ischaemia–reperfusion.Conclusion: Coordinate NOGP activation in response to acute hyperglycaemia results in contractile dysfunction during ischaemia–reperfusion, allowing for the development of novel cardioprotective agents.
- 25 October 2013
- Published by Wiley in Acta Physiologica
- Vol. 210 (3) , 546-564
Detrimental effects of acute hyperglycaemia on the rat heart
Aim: Hyperglycaemia is an important risk factor for acute myocardial infarction. It can lead to increased induction of non‐oxidative glucose pathways (NOGPs) – polyol and hexosamine biosynthetic pathways, advanced glycation end products and protein kinase C – that may contribute to cardiovascular diseases onset. However, the precise underlying mechanisms remain poorly understood. Here we hypothesized that acute hyperglycaemia increases myocardial oxidative stress and NOGP activation resulting in cardiac dysfunction during ischaemia–reperfusion and that inhibition of, and/or shunting flux away from NOGPs [by benfotiamine (BFT) treatment], leads to cardioprotection.Methods: We employed several experimental systems: (i) Isolated rat hearts were perfused ex vivo with Krebs‐Henseleit buffer containing 33 mm glucose vs. controls (11 mm glucose) ± global ischaemia and reperfusion ± BFT (first 20 min of reperfusion); (ii) Infarct size determination as per the ischaemic protocol, but with regional ischaemia and reperfusion ± BFT treatment; in separate experiments, NOGP inhibitors were also employed for (i) and (ii); and (iii) In vivo coronary ligations performed on streptozotocin‐treated rats ± BFT treatment (early reperfusion).Results: Acute hyperglycaemia generated myocardial oxidative stress, NOGP activation and apoptosis, but caused no impairment of cardiac function during pre‐ischaemia, thereby priming hearts for later damage. Following ischaemia–reperfusion (under hyperglycaemic conditions), such effects were exacerbated together with cardiac contractile dysfunction. Moreover, inhibition of respective NOGPs and shunting away by BFT treatment (in part) improved cardiac function during ischaemia–reperfusion.Conclusion: Coordinate NOGP activation in response to acute hyperglycaemia results in contractile dysfunction during ischaemia–reperfusion, allowing for the development of novel cardioprotective agents.